Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Other

S16 Ep55: OncoBytes Adaptive Learning Pathways: Personalizing Treatment Plans to Optimize Adjuvant Therapy in Early-Stage HR+/HER2- Breast Cancer

 April 20, 2026

OncLive Podcast

In this podcast, experts Joyce O’Shaughnessy, MD; Virginia Kaklamani, MD, DSc; and Seth A.

OtherOncologyRead full story

Post navigation

Beyond GLP-1Rs: emerging targets poised to gain share of obesity market →
← Novo’s late-stage sickle cell win piles pressure on competitors

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com